|
|
||||||||
|
FIGURE 5. Relationship between red marrow dose derived from whole-blood timeactivity curve for 186Re-cMAb U36 and percentage decrease from baseline platelet count (r = 0.6; P < 0.05).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |